These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4269401)

  • 1. Allograft immunity in vitro. V. Generation of cytotoxic effector cells in mixed lymphocyte culture and the specificity of target cell lysis.
    Andersson LC; Häyry P
    Cell Immunol; 1973 Sep; 8(3):470-83. PubMed ID: 4269401
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between proliferative and effector phases of the mixed lymphocyte reaction and graft-vs-host reaction.
    Howe M; Berman L; Cohen L
    J Immunol; 1973 Oct; 111(4):1243-9. PubMed ID: 4147022
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific priming of mouse thymus-dependent lymphocytes to allogeneic cells in vitro.
    Andersson LC; Häyry P
    Eur J Immunol; 1973 Sep; 3(9):595-9. PubMed ID: 4271927
    [No Abstract]   [Full Text] [Related]  

  • 4. Mastocytoma-medicated suppression of mixed lymphocyte culture and mitogen responsiveness.
    DeLustro F; Argyris BF
    Cell Immunol; 1976 Jan; 21(1):177-84. PubMed ID: 129285
    [No Abstract]   [Full Text] [Related]  

  • 5. Arming of macrophages with lymphocytes from mice immunized with tumor tissue.
    Horowitz M; Argyris BF
    Immunol Commun; 1977; 6(3):297-319. PubMed ID: 69610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic recognition and killing capacity of immune macrophages in mixed macrophage cultures (MMC).
    Gallily R
    Cell Immunol; 1975 Feb; 15(2):419-31. PubMed ID: 122917
    [No Abstract]   [Full Text] [Related]  

  • 7. Requirement for macrophages in lipopolysaccharide-stimulated mixed thymocyte cultures.
    Ritter J; Lohmann-Matthes ML; Sonntag HG; Fischer H
    Cell Immunol; 1975 Mar; 16(1):153-61. PubMed ID: 123174
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic unresponsiveness of mouse spleen sensitized to allogenic tumors.
    Argyris BF; DeLustro F
    Cell Immunol; 1977 Feb; 28(2):390-403. PubMed ID: 139208
    [No Abstract]   [Full Text] [Related]  

  • 9. Macrophage cytotoxicity in the mouse immune response against a skin allograft.
    Dimitriu A; Dy M; Thomson N; Hamburger J
    J Immunol; 1975 Jan; 114(1 Pt 1):195-9. PubMed ID: 122985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary characterization of the cell in nu/nu mice that responds in the mixed leukocyte reaction.
    Croy BA; Osoba D
    Clin Immunol Immunopathol; 1975 Jul; 4(2):291-303. PubMed ID: 124639
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrophage-mediated cytotoxicity against allogeneic target cells in vitro.
    Lohmann-Matthes ML; Schipper H; Fischer H
    Eur J Immunol; 1972 Feb; 2(1):45-9. PubMed ID: 4263647
    [No Abstract]   [Full Text] [Related]  

  • 12. Properties of fractionated spleen cells from NZB/W mice.
    Garner GM; Gershwin ME; Steinberg AD
    Cell Immunol; 1975 Jan; 15(1):129-42. PubMed ID: 45836
    [No Abstract]   [Full Text] [Related]  

  • 13. Reactivity of steroid-resistant neonatal thymocytes.
    Cohen PL; Mosier DE
    Nature; 1974 Sep; 251(5472):233-4. PubMed ID: 4138862
    [No Abstract]   [Full Text] [Related]  

  • 14. The nonspecific helper effect of mixed lymphocyte reactions on the induction of T cell-mediated immunity in vitro.
    Altman A; Cohen IR
    Eur J Immunol; 1974 Aug; 4(8):577-80. PubMed ID: 4278331
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of lymphocyte cytotoxicity by modification of the effector or target cells with periodate or with neuraminidase and galactose oxidase.
    Novogrodsky A
    J Immunol; 1975 Mar; 114(3):1089-93. PubMed ID: 163281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization and specificity of murine anti-tumor cytotoxic effector cells within an ascitic tumor.
    Biddison WE; Palmer JC; Alexander MA; Cowan EP; Manson LA
    J Immunol; 1977 Jun; 118(6):2243-53. PubMed ID: 68083
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of nonspecific cytotoxicity in graft-versus-host reaction as a function of target cell type.
    Singh JN; Sabbadini E; Sehon AH
    Cell Immunol; 1973 Aug; 8(2):280-9. PubMed ID: 4146905
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immunity to Murine tumor allografts. Increase in the activities of activated thymus-derived cells following in vitro incubation.
    Gorczynski RM; Tigelaar RE
    Cell Immunol; 1975 Jul; 18(1):121-43. PubMed ID: 806353
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in the effects of adult thymectomy on T-cell mediated responses in vitro.
    Andersson LC; Häyry P; Bach MA; Bach JF
    Nature; 1974 Nov; 252(5480):252-4. PubMed ID: 4278652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.